subject area of
- A High Proportion of Canadian Allergists Offer Oral Immunotherapy but Barriers Remain Academic Article
- AR101 Oral Immunotherapy for Peanut Allergy Academic Article
- Cannabinoid WIN55212‐2 impairs peanut‐allergic sensitization and promotes the generation of allergen‐specific regulatory T cells Academic Article
- Comprehensive metabolomics identifies the alarmin uric acid as a critical signal for the induction of peanut allergy Academic Article
- Concurrent blockade of platelet-activating factor and histamine prevents life-threatening peanut-induced anaphylactic reactions Academic Article
- Conflicting verdicts on peanut oral immunotherapy from the Institute for Clinical and Economic Review and US Food and Drug Administration Advisory Committee: Where do we go from here? Academic Article
- Disruption of T-cell immunoglobulin and mucin domain molecule (TIM)–1/TIM4 interaction as a therapeutic strategy in a dendritic cell–induced peanut allergy model Academic Article
- Distinct immune effector pathways contribute to the full expression of peanut-induced anaphylactic reactions in mice Academic Article
- ICER report for peanut OIT comes up short Academic Article
- Impact of CD40 Ligand, B Cells, and Mast Cells in Peanut-Induced Anaphylactic Responses Academic Article
- Impact of age on adherence and efficacy of peanut oral‐immunotherapy using a standardized protocol Academic Article
- Increasing Awareness of the Low Risk of Severe Reaction at Infant Peanut Introduction: Implications During COVID-19 and Beyond Academic Article
- Intentional poisoning with peanut as a cause of recurrent anaphylaxis Academic Article
- International Peanut Allergy Prevention, 6 Years After the Learning Early About Peanut Study Academic Article
- Interrupting reactivation of immunologic memory diverts the allergic response and prevents anaphylaxis Academic Article
- Modeling the conversion between specific IgE test platforms for nut allergens in children and adolescents Academic Article
- Oral immunotherapy for peanut allergy (PACE): a systematic review and meta-analysis of efficacy and safety Academic Article
- Participant characteristics and safety outcomes of peanut oral immunotherapy in the RAMSES and ARC011 trials Academic Article
- Passive Transfer of Peanut Hypersensitivity by Fresh Frozen Plasma Academic Article
- Peanut Oral Immunotherapy With or Without H1 and H2 Antihistamine Premedication for Peanut Allergy (PISCES): A Placebo-Controlled Randomized Clinical Trial Academic Article
- Peanut allergen reaction thresholds during controlled food challenges in 2 Canadian randomized studies (Canada-ARM1 and PISCES) Academic Article
- Peanut allergy diagnosis: A 2020 practice parameter update, systematic review, and GRADE analysis Academic Article
- Peanut cross-contamination in randomly selected baked goods Academic Article
- Reduced peanut sensitization with maternal peanut consumption and early peanut introduction while breastfeeding Academic Article
- Risk of peanut- and tree-nut–induced anaphylaxis during Halloween, Easter and other cultural holidays in Canadian children Academic Article
- Role of food labels in accidental exposures in food-allergic individuals in Canada Academic Article
- T helper cell IL-4 drives intestinal Th2 priming to oral peanut antigen, under the control of OX40L and independent of innate-like lymphocytes Academic Article
- The global burden of illness of peanut allergy: A comprehensive literature review Academic Article
- Timing of food introduction and development of food sensitization in a prospective birth cohort Academic Article
- Virtually supported home peanut introduction during COVID-19 for at-risk infants Academic Article
- Weighing peanut candies used for oral immunotherapy mitigates variable peanut protein dose Academic Article